29 related articles for article (PubMed ID: 38642607)
1. Long noncoding RNA TUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta.
Sonobe R; Yang P; Suzuki MM; Shinjo K; Iijima K; Nishiyama N; Miyata K; Kataoka K; Kajiyama H; Kondo Y
Cancer Sci; 2024 Jun; 115(6):1910-1923. PubMed ID: 38558246
[TBL] [Abstract][Full Text] [Related]
2. HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer.
Li X; Zheng Z; Zhou W; Huang H; Zhou Y; Xu Q; Zhu X; Teng Y
J Ovarian Res; 2024 Jun; 17(1):124. PubMed ID: 38851728
[TBL] [Abstract][Full Text] [Related]
3. Long Non-coding RNA UCA1 Regulates SRPK1 Expression Through miR- 99b-3p in Ovarian Cancer.
Xu J; Zheng LH; Hong YN; Xuan C; Yan SL; Lv GL; Jiang ZG; Ding XF
Protein Pept Lett; 2022; 29(10):829-838. PubMed ID: 35794743
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
5. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
Li Z; Niu H; Qin Q; Yang S; Wang Q; Yu C; Wei Z; Jin Z; Wang X; Yang A; Chen X
Mol Ther Nucleic Acids; 2019 Sep; 17():92-101. PubMed ID: 31234009
[TBL] [Abstract][Full Text] [Related]
6. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.
Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN
Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607
[TBL] [Abstract][Full Text] [Related]
7. The Role of Urothelial Cancer-Associated 1 in Gynecological Cancers.
Nousiopoulou E; Vrettou K; Damaskos C; Garmpis N; Garmpi A; Tsikouras P; Nikolettos N; Nikolettos K; Psilopatis I
Curr Issues Mol Biol; 2024 Mar; 46(3):2772-2797. PubMed ID: 38534790
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UCA1 in anti-cancer drug resistance.
Wang H; Guan Z; He K; Qian J; Cao J; Teng L
Oncotarget; 2017 Sep; 8(38):64638-64650. PubMed ID: 28969100
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value and mechanisms of lncRNA UCA1 in human cancer.
Yao F; Wang Q; Wu Q
Cancer Manag Res; 2019; 11():7685-7696. PubMed ID: 31616184
[TBL] [Abstract][Full Text] [Related]
10. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer.
Xue M; Chen W; Li X
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1407-19. PubMed ID: 26341664
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
